Delivery Order SPE2DB24D8003-SPE2DB25FJTPF
Award Date
1/3/25
Potential Completion Date
1/6/25
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract, which is not set aside, has a ceiling value of $2,980.06 and a period of performance through October 29, 2024. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical's ECAT Generation V...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the purchase of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a total ceiling value of $15,933.58 and a period of performance through November 18, 2024. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division under the ECAT...
This is a delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) for the procurement of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML pharmaceutical products. The contract has a ceiling value of $1,550.66 and a period of performance through December 16, 2024. It is a firm fixed-price contract, with no set-aside designation.
Dakota Drug, Inc. is a key supplier to the DLA's Troop Support Medical division, providing a wide...
This federal contract award, valued at $2,661.64, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of the pharmaceutical product "WEGOVY 0.5 MG/0.5 ML PEN 0.5ML" and has a performance period through November 8, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense. This award is a delivery...
This federal contract award, valued at $3,071.33, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, which has an ultimate completion date of September 25, 2024.
Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, under the DLA Troop Support Medical's...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKYVE, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,147.45 firm fixed-price delivery order is for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. This award is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, valued at $999,999,999.00. The IDC, which is part of the DLA's...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the procurement of 0.25 mg/0.5 mL pens of the pharmaceutical product WEGOVY. The contract has a ceiling value of $3,634.12 and a performance period ending on January 3, 2025. This contract award is part of Dakota Drug, Inc.'s existing Indefinite Delivery Contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, which allows the company...
This firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit Subchapter S corporation. The $3,563.88 award is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. This contract supports the DLA Troop Support Medical's mission of providing comprehensive medical supply chain operations for the U.S. Armed Forces. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the procurement of the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The contract has a firm fixed price ceiling value of $1,789.24 and a period of performance through December 3, 2024.
This delivery order is part of a larger Indefinite Delivery Contract (IDC) vehicle, SPE2DB24D8001, valued at $999,999,999.00, which allows Dakota...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit Subchapter S corporation. The contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product, with a potential value of $1,239.76 and a completion date of December 27, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. Dakota...